PhD candidate and Master in Pharmaceutical Sciences at the Department of Pharmaceutical Products (PFA) of the School of Pharmacy at UFMG. Bachelor of Pharmacy (2016-2022) from the same institution. During his undergraduate studies, he worked as a volunteer scientific initiation fellow (PRPQ) in the areas of natural products chemistry and phytochemistry. He was also a scientific initiation fellow (PIBIC, CNPq) in the fields of drug design and molecular modeling. He served as a teaching assistant in Pharmaceutical and Medicinal Chemistry at the Department of Pharmaceutical Products at the School of Pharmacy at UFMG. He was honored with the Academic Relevance Award in the Life Sciences Major Knowledge Area during the 2020 Scientific Initiation Week. He completed an internship (2021-2022) at the Ezequiel Dias Foundation in the Biological Products Development Service, where he worked on the development and optimization of production processes for hyperimmune heterologous sera and recombinant proteins. His PhD project focuses on the design of potential inhibitors of the FAAH enzyme with analgesic activity against pain and acute inflammation.
PhD candidate and Master in Pharmaceutical Sciences at the Department of Pharmaceutical Products (PFA) of the School of Pharmacy at UFMG. Bachelor of Pharmacy (2016-2022) from the same institution. During his undergraduate studies, he worked as a volunteer scientific initiation fellow (PRPQ) in the areas of natural products chemistry and phytochemistry. He was also a scientific initiation fellow (PIBIC, CNPq) in the fields of drug design and molecular modeling. He served as a teaching assistant in Pharmaceutical and Medicinal Chemistry at the Department of Pharmaceutical Products at the School of Pharmacy at UFMG. He was honored with the Academic Relevance Award in the Life Sciences Major Knowledge Area during the 2020 Scientific Initiation Week. He completed an internship (2021-2022) at the Ezequiel Dias Foundation in the Biological Products Development Service, where he worked on the development and optimization of production processes for hyperimmune heterologous sera and recombinant proteins. His PhD project focuses on the design of potential inhibitors of the FAAH enzyme with analgesic activity against pain and acute inflammation.